The incidence of postoperative NAFLD was 4.85%, and adjuvant chemotherapy with S-1 and high level of serum cholinesterase were considered as the risk factors for NAFLD occurring after gastrectomy for gastric cancer [35]. Here, BCHE is linked to metabolic dysfunction-associated steatotic liver disease.